Pfizer supports Innovation Lecture
|Pfizer supports Innovation Lecture|
|May 17, 2012|
Pfizer knows about innovation. The pharmaceutical company has a leading portfolio of more than 30 products and medicines that support wellness and prevention, as well as treatments for cancer, cardiovascular diseases and a broad range of other therapeutic areas.
As a generous sponsor of the School’s Innovation Lecture Series, Pfizer supported an April 3 talk by Joseph M. DeSimone, PhD, Chancellor’s Eminent Professor of Chemistry at UNC, about “The Cost-Effective Design of Vaccines and Therapeutics.”
“Pfizer is committed to finding sustainable solutions to the most pressing healthcare challenges,” says Carmine Novembre, MPH, CPH, MSc, of Pfizer’s External Medical Affairs. “Vaccines play an essential role in disease prevention and preservation of public health, and we are proud to support the UNC Gillings School of Global Public Health in bringing together thought leaders to promote discussion and innovation in this important area.”
Thanks to Pfizer and other donors for bringing learning opportunities to the School! Learn more at www.sph.unc.edu/giving.
Carolina Public Health is a publication of the University of North Carolina at Chapel Hill Gillings School of Global Public Health. To view previous issues, please visit www.sph.unc.edu/cph.
Last updated June 29, 2012